Free Trial

BI Asset Management Fondsmaeglerselskab A S Buys 58,525 Shares of Cardinal Health, Inc. (NYSE:CAH)

Cardinal Health logo with Medical background

BI Asset Management Fondsmaeglerselskab A S raised its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 183.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 90,380 shares of the company's stock after purchasing an additional 58,525 shares during the period. BI Asset Management Fondsmaeglerselskab A S's holdings in Cardinal Health were worth $10,689,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Norges Bank acquired a new position in shares of Cardinal Health during the 4th quarter worth approximately $246,748,000. Marshall Wace LLP grew its stake in shares of Cardinal Health by 154.6% in the fourth quarter. Marshall Wace LLP now owns 3,151,736 shares of the company's stock valued at $372,756,000 after buying an additional 1,913,892 shares in the last quarter. Bank of Nova Scotia increased its holdings in Cardinal Health by 1,142.4% during the fourth quarter. Bank of Nova Scotia now owns 545,313 shares of the company's stock worth $64,494,000 after buying an additional 501,421 shares during the last quarter. Raymond James Financial Inc. bought a new stake in Cardinal Health during the fourth quarter worth $45,115,000. Finally, Renaissance Group LLC lifted its stake in Cardinal Health by 4,375.6% in the fourth quarter. Renaissance Group LLC now owns 265,044 shares of the company's stock valued at $31,347,000 after acquiring an additional 259,122 shares during the last quarter. Institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Up 1.1 %

Shares of NYSE:CAH traded up $1.42 during trading on Thursday, reaching $135.85. 1,588,006 shares of the company traded hands, compared to its average volume of 2,183,954. The firm has a market capitalization of $32.82 billion, a PE ratio of 25.35, a PEG ratio of 1.49 and a beta of 0.61. The company's 50 day moving average is $130.40 and its two-hundred day moving average is $123.61. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $139.50.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st were issued a $0.5056 dividend. The ex-dividend date was Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a yield of 1.49%. Cardinal Health's dividend payout ratio (DPR) is presently 37.69%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CAH. Jefferies Financial Group raised shares of Cardinal Health from a "hold" rating to a "buy" rating and upped their target price for the company from $140.00 to $150.00 in a report on Wednesday, February 5th. Evercore ISI raised Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price objective for the company in a research report on Tuesday, January 7th. Argus set a $148.00 target price on Cardinal Health in a research note on Tuesday, February 4th. Wells Fargo & Company increased their price target on Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a research note on Tuesday, February 4th. Finally, Morgan Stanley upped their price objective on shares of Cardinal Health from $136.00 to $142.00 and gave the company an "overweight" rating in a report on Friday, January 31st. Four research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. According to data from MarketBeat, Cardinal Health has a consensus rating of "Moderate Buy" and an average price target of $140.86.

Read Our Latest Stock Report on CAH

Cardinal Health Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Featured Articles

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Should You Invest $1,000 in Cardinal Health Right Now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines